
Treatment-Experienced - ARV Regimen Simplification
Target Audience
Learning Objectives
- Utilize current and emerging data on HIV therapies and treatment paradigms to improve the treatment of HIV-positive patients;
- Address and reduce side effects from ARVs that can interfere with adherence to ARV regimens;
- Understand and apply in a clinical setting information about new paradigms and approaches to treating and managing HIV, including potential two-drug ARV combinations;
- Provide rapid initiation of ARV therapy following an HIV diagnosis;
- Apply new and emerging information on long-acting ARVs to their clinical practice;
- Discuss future directions in HIV treatment and HIV cure research.
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Participation
FACULTY
Professor of Medicine, School of Medicine Chief
Division of Infectious Diseases
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Clinical Director
Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
(Course Reviewer)
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and Viral Ed Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Health Professions Credit
Please Note: The credit claiming process will close three months after the activity end date. Requests to claim credit after three months will be subject to additional fees.